ClinConnect ClinConnect Logo
Search / Trial NCT05505019

Targeting Apathy With Music in Parkinson's Disease

Launched by UNIVERSITY OF BRITISH COLUMBIA · Aug 15, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Music Music Intervention Non Motor Symptoms

ClinConnect Summary

This clinical trial is exploring how listening to music might help reduce apathy, or lack of motivation and emotion, in people with Parkinson's Disease (PD). Apathy is a common symptom in PD that doesn’t currently have any specific treatments, so this study is looking at how music can positively affect the brain and improve this condition. Researchers believe that music could be a simple and enjoyable way to help those living with PD feel more engaged and motivated.

To be eligible for the study, participants need to have a clinical diagnosis of Parkinson's Disease. However, people with certain other conditions, such as atypical Parkinsonism, epilepsy, significant cognitive impairment, or those who have had specific surgeries or have metal implants, won't be able to participate. If you or a loved one qualifies and decides to join, you'll have the opportunity to explore how music can impact your experience with PD, contributing to valuable research. Overall, this study aims to find new ways to support patients dealing with apathy in their everyday lives.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - Clinical diagnosis of Parkinson's Disease following MDS Parkinson's disease criteria
  • Exclusion Criteria:
  • Participants with atypical Parkinsonism (eg. Progressive supranuclear palsy, multiple system atrophy, drug induced, etc.)
  • Epilepsy
  • Other neurological disease/complications (eg. myopathy, stroke, brain lesion, MS)
  • Significant cognitive impairment (MoCa \<21)
  • Moderate depression (Beck's Depression Inventory \>20)
  • Severe/multiple head trauma(s)
  • Participants with metal/medical implants, including any of the following: artificial heart valve, brain aneurysm clip, electrical stimulators, ear or eye implant, implanted drug infusion pump, coil, catheter, or filter in any blood vessel, orthopedic hardware such as artificial joint, plate, and/or screws, other metallic prostheses, shrapnel, bullets, or other metal fragments, surgery or tattoos, including tattooed eyeliner, in the last six weeks, cardiac pacemaker, wires or defibrillator, or ferromagnetic aneurysm clip)
  • Participants who have gone through specific injuries/brain surgery (eg. an injury where a piece of metal lodged in the eye or orbit)

About University Of British Columbia

The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.

Locations

Vancouver, British Columbia, Canada

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials